Drug Research
Sai Life Sciences Opens High-Potency API Manufacturing Facility
Sai Life Sciences, one of India's fastest growing contract research, development and manufacturing organizations (CRO-CDMO), has opened a new high-potency API (HPAPI) manufacturing facility...
Drug Research
Charles River and Rznomics Announce RNA-based Anticancer Gene Therapy Manufacturing Alliance
Charles River Laboratories International, Inc. and Rznomics Inc., a South Korea-based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, announced a viral...
News
Strength in sustainability: Vetter wins gold in EcoVadis ranking
Vetter significantly increases its sustainability rating.
We achieved gold status in the renowned, independent EcoVadis sustainability ranking. With 72 points out of a maximum of...
Industry Reports
Sun Pharma to Acquire Concert Pharmaceuticals for $576M
Sun Pharmaceutical Industries and Concert Pharmaceuticals, Inc. entered a definitive agreement under which Sun Pharma will acquire Concert through an upfront payment of $576...
Drug Research
Forge Biologics Receives PRIME Designation from EMA for Novel Gene Therapy
Forge Biologics, a gene therapy-focused contract development and manufacturing organization (CDMO), said that the European Medicines Agency (EMA) has granted priority medicines (PRIME) designation...
Clinical Trials
UK- Perfect Destination For Conducting ATMP Clinical Trials
The UK Advanced Therapy Medicinal Products (ATMP) Clinical Trials Report 2022 has been published by Cell and Gene Therapy (CGT).
T cells were said to...
Drug Research
Microbiome Industry Explores Hong Kong As APAC Region Centre
To host the Microbiome Summit 2023 at the Hong Kong Science Park, the medicine faculty of the Chinese University of Hong Kong, Hong Kong...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read